REGISTERED NUMBER: 08635708 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 August 2025

for

Nazli Medics Limited

Page

Balance Sheet

1

FIXED ASSETS

2,026

-

CURRENT ASSETS

9,802

13,159

CREDITORS

Amounts falling due within one year

(9,900

)

(8,112

)

NET CURRENT (LIABILITIES)/ASSETS

(98

)

5,047

TOTAL ASSETS LESS CURRENT LIABILITIES

1,928

5,047

CREDITORS

Amounts falling due after more than one year

-

(4,649

)

NET ASSETS

1,928

398

CAPITAL AND RESERVES

1,928

398

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Nazli Medics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

08635708

Registered office:

1 Lower Green

Loughborough

Leicestershire

LE11 3PA

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 1 ) .

3.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 August 2025 and 31 August 2024:

2025

2024

£

£

Dr S Rahman

Balance outstanding at start of year

9,930

15,856

Amounts advanced

-

9,930

Amounts repaid

(9,930

)

(15,856

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

9,930

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 29 May 2026 and were signed on its behalf by:

Dr S Rahman - Director